Screener
Lexicon Pharmaceuticals LXRX Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Royalties and other revenue | 12 | — | 24 | — |
| Total revenues | 692 | 28,866 | 21,794 | 30,128 |
| Operating expenses: | ||||
| Cost of sales | 39 | 33 | 147 | 63 |
| Research and development, including stock-based compensation of $1,384, $1,620, $2,753, and $3,194 respectively | 17,443 | 15,747 | 30,199 | 31,050 |
| Selling, general and administrative, including stock-based compensation of $1,952, $1,575, $3,661, and $3,044 respectively | 9,750 | 9,350 | 18,984 | 20,958 |
| Total operating expenses | 27,232 | 25,130 | 49,330 | 52,071 |
| (Loss) income from operations | (26,540) | 3,736 | (27,536) | (21,943) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's total cost of revenue?
- Lexicon Pharmaceuticals (LXRX) reported total cost of revenue of $39K in Q2 2026.
- How has Lexicon Pharmaceuticals's total cost of revenue changed year-over-year?
- Lexicon Pharmaceuticals's total cost of revenue increased by 18.2% year-over-year, from $33K to $39K.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Lexicon Pharmaceuticals's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude